Related Experiment Video
Updated: Aug 9, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Gene therapy for HIV infection: what does it need to make it work?
Dorothee von Laer1, Susanne Hasselmann, Klaus Hasselmann
1Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42, Frankfurt a.M., Germany. laer@em.uni-frankfurt.de
Abstract:
The efficacy of antiviral drug therapy for HIV infection is limited by toxicity and viral resistance. Thus, alternative therapies need to be explored. Several gene therapeutic strategies for HIV infection have been developed, but in clinical testing therapeutically effective levels of the transgene product were not achieved. This review focuses on the determinants of therapeutic efficacy and discusses the potential and also the limits of current gene therapy approaches for HIV infection.
Related Concept Videos
Gene Therapy
Gene Therapy
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Microorganisms in Medicine and Therapeutics
Inhibitors of Viral Protein Synthesis

